Insider Transactions in Q4 2025 at Karyopharm Therapeutics Inc. (KPTI)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 15
2025
|
Michael Mano SVP, General Counsel&Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
43,650
+40.15%
|
-
|
|
Oct 15
2025
|
Stuart Poulton EVP, Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
39,682
+37.06%
|
-
|
|
Oct 15
2025
|
Kristin Abate Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,799
+35.91%
|
-
|
|
Oct 15
2025
|
Lori Macomber EVP, CFO & Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
43,650
+44.56%
|
-
|
|
Oct 15
2025
|
Sohanya Roshan Cheng EVP & Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
43,650
+35.44%
|
-
|
|
Oct 15
2025
|
Richard A. Paulson President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
114,285
+36.56%
|
-
|
|
Oct 01
2025
|
Kristin Abate Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
362
-3.48%
|
$2,172
$6.3 P/Share
|